Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Depreciation and Depletion (2019 - 2021)

Historic Depreciation and Depletion for Neurocrine Biosciences (NBIX) over the last 3 years, with Q4 2021 value amounting to $3.0 million.

  • Neurocrine Biosciences' Depreciation and Depletion rose 3636.36% to $3.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $10.9 million, marking a year-over-year increase of 2674.42%. This contributed to the annual value of $23.5 million for FY2024, which is 3202.25% up from last year.
  • Neurocrine Biosciences' Depreciation and Depletion amounted to $3.0 million in Q4 2021, which was up 3636.36% from $2.8 million recorded in Q3 2021.
  • Neurocrine Biosciences' 5-year Depreciation and Depletion high stood at $3.0 million for Q4 2021, and its period low was $1.6 million during Q1 2019.
  • For the 3-year period, Neurocrine Biosciences' Depreciation and Depletion averaged around $2.2 million, with its median value being $2.2 million (2020).
  • In the last 5 years, Neurocrine Biosciences' Depreciation and Depletion skyrocketed by 1000.0% in 2020 and then surged by 3636.36% in 2021.
  • Neurocrine Biosciences' Depreciation and Depletion (Quarter) stood at $2.0 million in 2019, then rose by 10.0% to $2.2 million in 2020, then surged by 36.36% to $3.0 million in 2021.
  • Its Depreciation and Depletion stands at $3.0 million for Q4 2021, versus $2.8 million for Q3 2021 and $2.6 million for Q2 2021.